Clinical Trial Update: Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Nebivolol for angina in women with microvascular disease; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Angina

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Microvascular Angina | Phase 4 | Status: COMPLETED | Results posted: 2017-04-20